Scotland is lagging behind England in improving its NHS performance in the wake of the covid pandemic. An analysis by the Institute for Fiscal Studies has found that while hospital activity and waiting times have improved in England, no similar uplift has occurred in Scotland.1 "NHS performance...
Previous studies on the natural history of long-COVID have been few and selective. Without comparison groups, disease progression cannot be differentiated from symptoms originating from other causes. The Long-COVID in Scotland Study (Long-CISS) is a Scotland-wide, general population cohort of adult...
The COVID-19 pandemic is having a lasting impact on health and well-being. We compare current self-reported health, quality of life and symptom profiles for people with ongoing symptoms following COVID-19 to those who have never tested positive for SARS-
11 If yes and tested positive, have you had symptoms that have persisted for longer than 12 weeks, since contracting COVID? Empty Cell Yes Empty Cell No Empty Cell Prefer not to say 12 Have you had any household members that have tested positive for COVID-19? Empty Cell Yes Empty Cell...
New NHS Scotland guidance criticised by BDA STIRLING, UK: Earlier this week, NHS Scotland released new guidance for the prevention and handling of potential respiratory infections in healthcare ... share save NewsWed. 1. December 2021 COVID-19: Study shows benefits of local exhaust ventilation ...
Trust in the UK Government was relatively low at 48 percent. Compared to those in England, respondents in other UK nations were more likely to trust their respective governments' information—with the rates in Scotland at 63 percent and Wales at 64 percent. The lowest rates of trust in Govern...
Long COVID is the patient-coined term for the disease entity whereby persistent symptoms ensue in a significant proportion of those who have had COVID-19, whether asymptomatic, mild or severe. Estimated numbers vary but the assumption is that, of all those who had COVID-19 globally, at leas...
Since both diseases cause similar symptoms of difficulty breathing and coughing, the scarification of lungs of TB patients stands to be further damaged by COVID-19, as well as making patients more susceptible to infection [57]. TB clinics had to close due to lockdowns in several endemic ...
97 MOVe-OUT is a double-blind, placebo-controlled phase 3 trial that evaluated molnupiravir therapy starting within 5 days after onset of symptoms in nonhospitalized, unvaccinated patients with confirmed SARS-CoV-2 (including 2.2% patients with active cancer) and demonstrated a relative risk ...
(NHS) hospitals in England, Wales, and Scotland. It compared the rate of children and young people admission between the first and second wave of the disease in the UK. It showed that the severity of infection had not changed and that about 20% of the admitted children had asymptomatic/...